Cargando…

Association of Vascular Endothelial Growth Factor Gene Polymorphism With Renal Cell Carcinoma Risk

The conclusion of the relationship between vascular endothelial growth factor gene polymorphism and renal cell carcinoma risk was inconsistent. This study was performed to assess the relationship between vascular endothelial growth factor gene polymorphism and renal cell carcinoma risk using meta-an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jia-Quan, Kang, Xin-Li, Wang, Yang, Xu, Cong-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762057/
https://www.ncbi.nlm.nih.gov/pubmed/28593813
http://dx.doi.org/10.1177/1533034617712396
_version_ 1783291626571956224
author Zhou, Jia-Quan
Kang, Xin-Li
Wang, Yang
Xu, Cong-Jie
author_facet Zhou, Jia-Quan
Kang, Xin-Li
Wang, Yang
Xu, Cong-Jie
author_sort Zhou, Jia-Quan
collection PubMed
description The conclusion of the relationship between vascular endothelial growth factor gene polymorphism and renal cell carcinoma risk was inconsistent. This study was performed to assess the relationship between vascular endothelial growth factor gene polymorphism and renal cell carcinoma risk using meta-analysis. The association studies were identified from PubMed, Embase, and Web of Science, and eligible studies were included and calculated. Ten studies were included for this meta-analysis. vascular endothelial growth factor (VEGF) +405G > CC allele and GG genotype were associated with renal cell carcinoma risk for overall populations in this meta-analysis (C allele: odds ratio = 1.18, 95% confidence interval: 1.05-1.33, P = .004; CC genotype: odds ratio = 1.20, 95% confidence interval: 0.96-1.50, P = .12; GG genotype: odds ratio = 0.79, 95% confidence interval: 0.67-0.93, P = .004). Furthermore, VEGF +936C>T gene polymorphism and VEGF −2578 C>A gene polymorphism were associated with renal cell carcinoma risk for overall populations (+936C>T: T allele: odds ratio = 1.16, 95% confidence interval: 1.05-1.29, P = .004; TT genotype: odds ratio = 1.25, 95% confidence interval: 1.02-1.52, P = .03; CC genotype: odds ratio = 0.86, 95% confidence interval: 0.75-0.98, P = .03; −2578 C>A: A allele: odds ratio = 1.26, 95% confidence interval: 1.15-1.38, P < .00001; AA genotype: odds ratio = 1.39, 95% confidence interval: 1.16-1.67, P = .0004; CC genotype: odds ratio = 0.75, 95% confidence interval: 0.61-0.92, P = .006). However, VEGF −634G>C, VEGF −460T>C, VEGF −1154 G>A, and VEGF +1612 G>A gene polymorphisms were not associated with renal cell carcinoma risk. In conclusion, VEGF +405G>CC allele and GG genotype, VEGF +936C>T gene polymorphism, and VEGF −2578 C>A gene polymorphism were associated with renal cell carcinoma risk for overall populations. However, more studies should be performed to assess this relationship in the future.
format Online
Article
Text
id pubmed-5762057
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-57620572018-01-17 Association of Vascular Endothelial Growth Factor Gene Polymorphism With Renal Cell Carcinoma Risk Zhou, Jia-Quan Kang, Xin-Li Wang, Yang Xu, Cong-Jie Technol Cancer Res Treat Original Articles The conclusion of the relationship between vascular endothelial growth factor gene polymorphism and renal cell carcinoma risk was inconsistent. This study was performed to assess the relationship between vascular endothelial growth factor gene polymorphism and renal cell carcinoma risk using meta-analysis. The association studies were identified from PubMed, Embase, and Web of Science, and eligible studies were included and calculated. Ten studies were included for this meta-analysis. vascular endothelial growth factor (VEGF) +405G > CC allele and GG genotype were associated with renal cell carcinoma risk for overall populations in this meta-analysis (C allele: odds ratio = 1.18, 95% confidence interval: 1.05-1.33, P = .004; CC genotype: odds ratio = 1.20, 95% confidence interval: 0.96-1.50, P = .12; GG genotype: odds ratio = 0.79, 95% confidence interval: 0.67-0.93, P = .004). Furthermore, VEGF +936C>T gene polymorphism and VEGF −2578 C>A gene polymorphism were associated with renal cell carcinoma risk for overall populations (+936C>T: T allele: odds ratio = 1.16, 95% confidence interval: 1.05-1.29, P = .004; TT genotype: odds ratio = 1.25, 95% confidence interval: 1.02-1.52, P = .03; CC genotype: odds ratio = 0.86, 95% confidence interval: 0.75-0.98, P = .03; −2578 C>A: A allele: odds ratio = 1.26, 95% confidence interval: 1.15-1.38, P < .00001; AA genotype: odds ratio = 1.39, 95% confidence interval: 1.16-1.67, P = .0004; CC genotype: odds ratio = 0.75, 95% confidence interval: 0.61-0.92, P = .006). However, VEGF −634G>C, VEGF −460T>C, VEGF −1154 G>A, and VEGF +1612 G>A gene polymorphisms were not associated with renal cell carcinoma risk. In conclusion, VEGF +405G>CC allele and GG genotype, VEGF +936C>T gene polymorphism, and VEGF −2578 C>A gene polymorphism were associated with renal cell carcinoma risk for overall populations. However, more studies should be performed to assess this relationship in the future. SAGE Publications 2017-06-08 2017-12 /pmc/articles/PMC5762057/ /pubmed/28593813 http://dx.doi.org/10.1177/1533034617712396 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Articles
Zhou, Jia-Quan
Kang, Xin-Li
Wang, Yang
Xu, Cong-Jie
Association of Vascular Endothelial Growth Factor Gene Polymorphism With Renal Cell Carcinoma Risk
title Association of Vascular Endothelial Growth Factor Gene Polymorphism With Renal Cell Carcinoma Risk
title_full Association of Vascular Endothelial Growth Factor Gene Polymorphism With Renal Cell Carcinoma Risk
title_fullStr Association of Vascular Endothelial Growth Factor Gene Polymorphism With Renal Cell Carcinoma Risk
title_full_unstemmed Association of Vascular Endothelial Growth Factor Gene Polymorphism With Renal Cell Carcinoma Risk
title_short Association of Vascular Endothelial Growth Factor Gene Polymorphism With Renal Cell Carcinoma Risk
title_sort association of vascular endothelial growth factor gene polymorphism with renal cell carcinoma risk
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762057/
https://www.ncbi.nlm.nih.gov/pubmed/28593813
http://dx.doi.org/10.1177/1533034617712396
work_keys_str_mv AT zhoujiaquan associationofvascularendothelialgrowthfactorgenepolymorphismwithrenalcellcarcinomarisk
AT kangxinli associationofvascularendothelialgrowthfactorgenepolymorphismwithrenalcellcarcinomarisk
AT wangyang associationofvascularendothelialgrowthfactorgenepolymorphismwithrenalcellcarcinomarisk
AT xucongjie associationofvascularendothelialgrowthfactorgenepolymorphismwithrenalcellcarcinomarisk